European Medicines Agency (EMA) preparing guidance to tackle COVID-19 variants

EMA is developing guidance for manufacturers planning changes to existing COVID-19 vaccines. EMA will shortly publish a paper that will set out the data and studies needed to support these adaptations of the existing vaccines to current or future mutations of SARS-CoV-2.

Source:

European Medicines Agency